title: Response to "Is denosumab a long-term option for the treatment of parathyroid carcinoma?".
authors.affiliation: From the Endocrine Unit, Department of Medicine, Hospital Putrajaya, Pusat Pentadbiran Kerajaan Persekutuan, Presint 7, Putrajaya 62250, Malaysia tchinvoon@yahoo.com.
authors.forename: C V
authors.initials: CV
authors.lastname: Tong
authors.affiliation: From the Endocrine Unit, Department of Medicine, Hospital Putrajaya, Pusat Pentadbiran Kerajaan Persekutuan, Presint 7, Putrajaya 62250, Malaysia.
authors.forename: Z
authors.initials: Z
authors.lastname: Hussein
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy*; D010257:Paraneoplastic Syndromes / Q000188:drug therapy*; D010282:Parathyroid Neoplasms / Q000150:complications*
chemical_list: D061067:Antibodies, Monoclonal, Humanized